| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681607 | Brain Stimulation | 2017 | 9 Pages |
Abstract
- Attentional difficulties are common in Parkinson's disease dementia (PDD).
- Current pharmacological treatments have limited efficacy and have associated side effects.
- There is a paucity of well-controlled tDCS clinical trials in PDD.
- tDCS is tolerable and feasible in a PDD population.
- A single session of tDCS does not, however, benefit attentional function in PDD.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Greg J. Elder, James Ashcroft, Katrina da Silva Morgan, Marium Umme Kulsum, Rebecca Banerjee, Payel Chatterjee, Michael J. Firbank, Ian G. McKeith, Hrishikesh Kumar, John-Paul Taylor,